Ernst & Young has named Glen Giovanetti leader of its new Global Biotechnology Center in Boston, and appointed Scott Sarazen to the new position of global markets leader within the center. The biotech center connects E&Y professionals worldwide, enabling them to share their experience and information on current and emerging industry issues.
Giovanetti was previously business risk services leader for E&Y’s Pacific North West area. He has experience assisting biotechnology and medical device clients with strategic transactions including initial public offerings, public and private debt offerings, technology licensing and R&D contracts, and acquisitions.
Sarazen, who recently joined Ernst & Young, brings more than 18 years of private and public sector biotechnology industry experience to the firm. His previous positions include senior vice president for life sciences with the Massachusetts Development Finance Agency and director of global planning and development at Genzyme.
Ernst & Young issues Beyond Borders, an annual biotechnology report. The 2007 edition was released in April.